Previous close | 59.48 |
Open | 54.50 |
Bid | 54.37 x 100 |
Ask | 57.43 x 100 |
Day's range | 52.25 - 55.38 |
52-week range | 52.25 - 100.77 |
Volume | |
Avg. volume | 2,530,863 |
Market cap | 10.073B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Exact Sciences Corporation (NASDAQ:EXAS) Q1 2024 Earnings Call Transcript May 8, 2024 Exact Sciences Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. My name is Danica, and I will be your conference operator today. […]
Robust revenues from the Screening and Precision Oncology segments contributed to the Exact Sciences' (EXAS) first-quarter top line.
Exact Sciences stock tumbled early Thursday as fears of a sales slowdown spooked investors in the Cologuard maker.